Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tapimmune Inc (TPIVD)

Tapimmune Inc (TPIVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tapimmune Inc 50 N.Laura Street Suite 2500 Jacksonville FL 32202

www.tapimmune.com P: 904-516-5436

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

TapImmune Inc. is an immunotherapy company. It specializes in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. The Company also develops therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection. It is involved in the development of HER2/neu for the treatment of breast cancer; and Folate Receptor Alpha, for the treatment of breast and ovarian cancer. TapImmune Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 51,590
Shares Outstanding, K 8,380
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -34,070 K

Growth:

1-Year Return -11.59%
3-Year Return -32.01%
5-Year Return -96.72%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/21/16
Earnings Per Share ttm -0.48
EPS Growth vs. Prev Qtr 142.86%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 09/16/16

TPIVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -119.76%
Return-on-Assets % 501.55%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
60-Month Beta -1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar